药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Etretinate
Cangrelor
The risk or severity of adverse effects can be increased when Cangrelor is combined with Ursodeoxycholic acid.
Etretinate
Prasugrel
The risk or severity of adverse effects can be increased when Prasugrel is combined with Ursodeoxycholic acid.
Etretinate
Caplacizumab
The risk or severity of adverse effects can be increased when Caplacizumab is combined with Ursodeoxycholic acid.
Etretinate
Andrographolide
The risk or severity of adverse effects can be increased when Andrographolide is combined with Ursodeoxycholic acid.
Etretinate
Ibudilast
The risk or severity of adverse effects can be increased when Ibudilast is combined with Ursodeoxycholic acid.
Etretinate
Beraprost
The risk or severity of adverse effects can be increased when Beraprost is combined with Ursodeoxycholic acid.
Etretinate
Defibrotide
The risk or severity of adverse effects can be increased when Defibrotide is combined with Ursodeoxycholic acid.
Etretinate
Tesmilifene
The risk or severity of adverse effects can be increased when Tesmilifene is combined with Ursodeoxycholic acid.
Etretinate
Nimesulide
The risk or severity of adverse effects can be increased when Nimesulide is combined with Ursodeoxycholic acid.
Etretinate
Resveratrol
The risk or severity of adverse effects can be increased when Resveratrol is combined with Ursodeoxycholic acid.
Etretinate
Epoprostenol
The risk or severity of adverse effects can be increased when Epoprostenol is combined with Ursodeoxycholic acid.
Etretinate
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Ursodeoxycholic acid.
Etretinate
Ridogrel
The risk or severity of adverse effects can be increased when Ridogrel is combined with Ursodeoxycholic acid.
Etretinate
Cilostazol
The risk or severity of adverse effects can be increased when Cilostazol is combined with Ursodeoxycholic acid.
Etretinate
Reviparin
The risk or severity of bleeding and bruising can be increased when Reviparin is combined with Ursodeoxycholic acid.
Etretinate
Edetic acid
The risk or severity of bleeding and bruising can be increased when Edetic acid is combined with Ursodeoxycholic acid.
Etretinate
Troxerutin
The risk or severity of bleeding and bruising can be increased when Troxerutin is combined with Ursodeoxycholic acid.
Etretinate
Zinc citrate
The risk or severity of bleeding and bruising can be increased when Zinc citrate is combined with Ursodeoxycholic acid.
Etretinate
Dabigatran
The risk or severity of bleeding and bruising can be increased when Dabigatran is combined with Ursodeoxycholic acid.
Etretinate
Edetate calcium disodium anhydrous
The risk or severity of bleeding and bruising can be increased when Edetate calcium disodium anhydrous is combined with Ursodeoxycholic acid.